List of Tables
Table 1. Global Gefitinib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gefitinib Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gefitinib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gefitinib Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Gefitinib Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gefitinib Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gefitinib Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gefitinib Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gefitinib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gefitinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gefitinib, Product Type & Application
Table 12. Global Key Manufacturers of Gefitinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gefitinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gefitinib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gefitinib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gefitinib Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Gefitinib Sales Market Share by Region (2020-2025)
Table 19. Global Gefitinib Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Gefitinib Sales Market Share by Region (2026-2031)
Table 21. Global Gefitinib Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gefitinib Revenue Market Share by Region (2020-2025)
Table 23. Global Gefitinib Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gefitinib Revenue Market Share by Region (2026-2031)
Table 25. North America Gefitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gefitinib Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Gefitinib Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Gefitinib Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gefitinib Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gefitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gefitinib Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Gefitinib Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Gefitinib Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gefitinib Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gefitinib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gefitinib Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Gefitinib Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Gefitinib Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gefitinib Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gefitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gefitinib Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Gefitinib Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Gefitinib Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gefitinib Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gefitinib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gefitinib Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Gefitinib Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Gefitinib Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gefitinib Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gefitinib Sales (K Pcs) by Type (2020-2025)
Table 51. Global Gefitinib Sales (K Pcs) by Type (2026-2031)
Table 52. Global Gefitinib Sales Market Share by Type (2020-2025)
Table 53. Global Gefitinib Sales Market Share by Type (2026-2031)
Table 54. Global Gefitinib Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gefitinib Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gefitinib Revenue Market Share by Type (2020-2025)
Table 57. Global Gefitinib Revenue Market Share by Type (2026-2031)
Table 58. Global Gefitinib Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Gefitinib Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Gefitinib Sales (K Pcs) by Application (2020-2025)
Table 61. Global Gefitinib Sales (K Pcs) by Application (2026-2031)
Table 62. Global Gefitinib Sales Market Share by Application (2020-2025)
Table 63. Global Gefitinib Sales Market Share by Application (2026-2031)
Table 64. Global Gefitinib Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gefitinib Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gefitinib Revenue Market Share by Application (2020-2025)
Table 67. Global Gefitinib Revenue Market Share by Application (2026-2031)
Table 68. Global Gefitinib Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Gefitinib Price (USD/Pcs) by Application (2026-2031)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. AstraZeneca Gefitinib Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Qilu Pharmaceutical Company Information
Table 76. Qilu Pharmaceutical Description and Business Overview
Table 77. Qilu Pharmaceutical Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Qilu Pharmaceutical Gefitinib Product
Table 79. Qilu Pharmaceutical Recent Developments/Updates
Table 80. Natco Pharma Company Information
Table 81. Natco Pharma Description and Business Overview
Table 82. Natco Pharma Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. Natco Pharma Gefitinib Product
Table 84. Natco Pharma Recent Developments/Updates
Table 85. Celon Laboratories Company Information
Table 86. Celon Laboratories Description and Business Overview
Table 87. Celon Laboratories Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Celon Laboratories Gefitinib Product
Table 89. Celon Laboratories Recent Developments/Updates
Table 90. Hetero Drugs Company Information
Table 91. Hetero Drugs Description and Business Overview
Table 92. Hetero Drugs Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Hetero Drugs Gefitinib Product
Table 94. Hetero Drugs Recent Developments/Updates
Table 95. Dr Reddy's Laboratories Company Information
Table 96. Dr Reddy's Laboratories Description and Business Overview
Table 97. Dr Reddy's Laboratories Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. Dr Reddy's Laboratories Gefitinib Product
Table 99. Dr Reddy's Laboratories Recent Developments/Updates
Table 100. Zuventus Healthcare Company Information
Table 101. Zuventus Healthcare Description and Business Overview
Table 102. Zuventus Healthcare Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. Zuventus Healthcare Gefitinib Product
Table 104. Zuventus Healthcare Recent Developments/Updates
Table 105. United Biotech Company Information
Table 106. United Biotech Description and Business Overview
Table 107. United Biotech Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. United Biotech Gefitinib Product
Table 109. United Biotech Recent Developments/Updates
Table 110. Panacea Biotec Company Information
Table 111. Panacea Biotec Description and Business Overview
Table 112. Panacea Biotec Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. Panacea Biotec Gefitinib Product
Table 114. Panacea Biotec Recent Developments/Updates
Table 115. Cipla Company Information
Table 116. Cipla Description and Business Overview
Table 117. Cipla Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Cipla Gefitinib Product
Table 119. Cipla Recent Developments/Updates
Table 120. Glenmark Pharmaceuticals Company Information
Table 121. Glenmark Pharmaceuticals Description and Business Overview
Table 122. Glenmark Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. Glenmark Pharmaceuticals Gefitinib Product
Table 124. Glenmark Pharmaceuticals Recent Developments/Updates
Table 125. Nobel Ilac Sanayii Ve Ticaret Company Information
Table 126. Nobel Ilac Sanayii Ve Ticaret Description and Business Overview
Table 127. Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. Nobel Ilac Sanayii Ve Ticaret Gefitinib Product
Table 129. Nobel Ilac Sanayii Ve Ticaret Recent Developments/Updates
Table 130. Accure Labs Company Information
Table 131. Accure Labs Description and Business Overview
Table 132. Accure Labs Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 133. Accure Labs Gefitinib Product
Table 134. Accure Labs Recent Developments/Updates
Table 135. Cadila Pharmaceuticals Company Information
Table 136. Cadila Pharmaceuticals Description and Business Overview
Table 137. Cadila Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 138. Cadila Pharmaceuticals Gefitinib Product
Table 139. Cadila Pharmaceuticals Recent Developments/Updates
Table 140. Ethypharm Company Information
Table 141. Ethypharm Description and Business Overview
Table 142. Ethypharm Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 143. Ethypharm Gefitinib Product
Table 144. Ethypharm Recent Developments/Updates
Table 145. Flagship Biotech International Company Information
Table 146. Flagship Biotech International Description and Business Overview
Table 147. Flagship Biotech International Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 148. Flagship Biotech International Gefitinib Product
Table 149. Flagship Biotech International Recent Developments/Updates
Table 150. Globela Pharma Company Information
Table 151. Globela Pharma Description and Business Overview
Table 152. Globela Pharma Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 153. Globela Pharma Gefitinib Product
Table 154. Globela Pharma Recent Developments/Updates
Table 155. Jodas Expoim Company Information
Table 156. Jodas Expoim Description and Business Overview
Table 157. Jodas Expoim Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 158. Jodas Expoim Gefitinib Product
Table 159. Jodas Expoim Recent Developments/Updates
Table 160. Nishchay Pharmaceuticals Company Information
Table 161. Nishchay Pharmaceuticals Description and Business Overview
Table 162. Nishchay Pharmaceuticals Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 163. Nishchay Pharmaceuticals Gefitinib Product
Table 164. Nishchay Pharmaceuticals Recent Developments/Updates
Table 165. Sichuan Xieli Pharmaceutical Company Information
Table 166. Sichuan Xieli Pharmaceutical Description and Business Overview
Table 167. Sichuan Xieli Pharmaceutical Gefitinib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 168. Sichuan Xieli Pharmaceutical Gefitinib Product
Table 169. Sichuan Xieli Pharmaceutical Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Gefitinib Distributors List
Table 173. Gefitinib Customers List
Table 174. Gefitinib Market Trends
Table 175. Gefitinib Market Drivers
Table 176. Gefitinib Market Challenges
Table 177. Gefitinib Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gefitinib
Figure 2. Global Gefitinib Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gefitinib Market Share by Type: 2024 & 2031
Figure 4. 10 Tables/Box Product Picture
Figure 5. 30 Tables/Box Product Picture
Figure 6. 90 Tables/Box Product Picture
Figure 7. Global Gefitinib Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Gefitinib Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Drug Center
Figure 12. Others
Figure 13. Global Gefitinib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gefitinib Market Size (2020-2031) & (US$ Million)
Figure 15. Global Gefitinib Sales (2020-2031) & (K Pcs)
Figure 16. Global Gefitinib Average Price (USD/Pcs) & (2020-2031)
Figure 17. Gefitinib Report Years Considered
Figure 18. Gefitinib Sales Share by Manufacturers in 2024
Figure 19. Global Gefitinib Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Gefitinib Players: Market Share by Revenue in Gefitinib in 2024
Figure 21. Gefitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Gefitinib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Gefitinib Sales Market Share by Country (2020-2031)
Figure 24. North America Gefitinib Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Gefitinib Sales Market Share by Country (2020-2031)
Figure 28. Europe Gefitinib Revenue Market Share by Country (2020-2031)
Figure 29. Germany Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Gefitinib Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Gefitinib Revenue Market Share by Region (2020-2031)
Figure 36. China Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Gefitinib Sales Market Share by Country (2020-2031)
Figure 47. Latin America Gefitinib Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Gefitinib Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Gefitinib Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Gefitinib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Gefitinib by Type (2020-2031)
Figure 57. Global Revenue Market Share of Gefitinib by Type (2020-2031)
Figure 58. Global Gefitinib Price (USD/Pcs) by Type (2020-2031)
Figure 59. Global Sales Market Share of Gefitinib by Application (2020-2031)
Figure 60. Global Revenue Market Share of Gefitinib by Application (2020-2031)
Figure 61. Global Gefitinib Price (USD/Pcs) by Application (2020-2031)
Figure 62. Gefitinib Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
